Eczema Future & Research

Eczema Future & Research

“Dupilumab met its safety endpoints and significantly outperformed placebo for adults with moderate to severe atopic dermatitis, according to final results of a multicenter, international phase IIb study.” according to edermatolygynews.com. It’s exciting to hear about a new drug on […]